#SelfcareTherapies 💙 Infertility affects millions of individuals and couples worldwide, creating emotional challenges. Some disorders are treatable with fertility hormone therapy to aid conception. Our solutions and partnerships with pharmaceutical companies worldwide make selfcare for patients simpler and easier. #Ypsomed #Healthcare #Selfcare #FertilityHormoneTherapy
Ypsomed AG
Herstellung medizinischer Geräte
Making selfcare simpler and easier.
Info
Ypsomed is the leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist. The company will celebrate its 40th anniversary in 2024. As a leader in innovation and technology, it is a preferred partner of pharmaceutical and biotech companies for pens, autoinjectors and pump systems for administering liquid medications. Ypsomed presents and markets its product portfolios under the umbrella brand mylife Diabetescare directly to patients, pharmacies and hospitals as well as under Ypsomed Delivery Systems in business-to-business operations with pharmaceutical companies. Ypsomed is headquartered in Burgdorf, Switzerland. The company has a global network of production facilities, subsidiaries and distribution partners. Ypsomed has over 2,200 employees worldwide.
- Website
-
https://www.ypsomed.com/en/company/ypsostories.html
Externer Link zu Ypsomed AG
- Branche
- Herstellung medizinischer Geräte
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Burgdorf
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2003
- Spezialgebiete
- diabetes care, manufacturer, injection systems, selfcare solutions, blood glucose monitoring systems, infusion systems, insulin pumps und digital health
Orte
-
Primär
Brunnmattstrasse 6
Burgdorf, 3401, CH
-
Weissensteinstrasse 26
Solothurn, 4503, CH
Beschäftigte von Ypsomed AG
-
Simon Michel
CEO and Member of the Board at Ypsomed Group and Member of the Swiss National Council
-
Kristen Garland, MAN, RD, CDE
-
Carlos Reboll Romero
General Manager | Sustainable Growth and Expansion | New Market Access | Product Commercialisation | Investment in People | Experience in Multiple…
-
Frederic Richard
Ypsomed Diabetes Care Business Development Director
Updates
-
"My desire for children made me choose mylife Loop" Rosanna, living with type 1 diabetes since age 14 💚. Read our interview with Rosanna, where she talks about her transition from Multiple Daily Injections (MDI) to the Automated Insulin Delivery (AID) system mylife Loop ⬇️. CamDiab, Dexcom, Abbott #mylifeloop #poweredbyCamAPSFX #mylifediabetescare #diabetesmanagement #diabetespregnancy #ypsomed ℹ️ mylife Loop is certified for pregnancy in some countries and in the approval process in others. For specific information about your location, please contact Ypsomed Diabetes Care.
-
The sun shone over the German champions' stadium in Leverkusen at the beginning of June with perfect footballing weather ⚽☀️. And with the sun shone the faces of 60 boys and girls aged 6 to 14 who had registered for the kids diabetes football camp at the Bayer 04 Leverkusen sports centre 😍. #mylifediabetescare #ypsomed #bayer04leverkusen #footballcamp
Kicking like the champions at Bayer 04 Leverkusen
mylife-diabetescare.com
-
#SelfcareTherapies 💙 We are grateful to contribute to the treatment of Growth Hormone Deficiency (GHD) by making therapies more accessible. GHD in children and adults results from an insufficient production of growth hormone, leading to growth failure in children and various health issues in adults, such as decreased muscle mass and bone density. Our solutions and partnerships with pharmaceutical companies worldwide make selfcare for patients simpler and easier. #Ypsomed #Selfcare #Healthcare #GrowthHormoneTherapy
-
Digital health solutions make selfcare simpler and easier for patients while also facilitating research and development, streamlining market access, and driving commercial success for pharmaceutical companies 🚀💙. In the latest issue of On Drug Delivery, Stefanie Seiler, PhD, Product Manager Digital Health, and Ventsislav Dobrev, Global Lead Digital Health, delve into the mechanics of these advancements. Discover how digital health is shaping the future of healthcare. #DigitalHealth #ypsomed #clinicaltrials #selfcaresolutions #marketaccess
-
In the 2023/24 season, the 24-year-old amateur player made it to the Bavarian South Regional League. Even the diagnosis of type 1 diabetes nine years ago could not stop her ⚽💪. Switching from pen therapy to mylife Loop has enabled her to focus even more on her sporting achievements. #poweredbyCamAPSFX #mylifeloop #football #ypsomed #diabetesmanagement
Success with mylife Loop: Sophia's football experiences
mylife-diabetescare.com
-
New blog post 🌍 We have delivered our first YpsoMate NetZero products, moving towards net zero emissions by 2040. Our NetZero Program focuses on renewable materials, optimized packaging, and improved supply chains, with ISCC certification for all sites. #Ypsomed #YpsomedPulse #Sustainability #NetZeroProgram #DrugDelivery #MedicalDevices
First deliveries of YpsoMate 1ml as part of the NetZero Program
yds.ypsomed.com
-
It was a fantastic second roundtable discussion at HLTH Europe organised by HealthXL and Ypsomed 👏. A special thanks goes to the senior pharma executives, who shared their knowledge from successes and failures in digital selfcare solutions. Together we can bring selfcare for patients on injectable drugs to the next level 🚀. #DigitalHealth #ypsomed #partnership #selfcaresolutions #InjectableTherapies
🌟 Exciting discussions at HLTH Europe! Recently, senior pharma executives from leading organizations gathered to explore the transformative potential of digital health solutions in injectables at our second roundtable with Ypsomed AG. We discussed aligning incentives among providers, manufacturers, and healthcare systems for widespread adoption. Tailoring digital solutions to specific use cases and integrating them early into drug development emerged as critical strategies. Looking ahead, we're focused on evolving the TPP into the TPDP (Target Product and Digital Profile) to seamlessly integrate digital solutions into how we are building the molecules. Exciting times ahead as we navigate the intersection of healthcare and technology, striving for integrated treatment solutions that optimize patient care. Let's continue to scale connectivity and drive meaningful innovations together! #DigitalHealth #PharmaInnovation #HLTHEurope
-
In the AiDAPT randomised controlled trial, women using the CamAPS FX hybrid closed-loop achieved a time in pregnancy range of 68.2%, an impressive +10.5% compared to the control group using CGM and MDI or pump therapy* 👍. CamDiab, Dexcom, Abbott #mylifeloop #mylifediabetescare #diabetesmanagement #diabetespregnancy #ypsomed * Lee T.M. et al: Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes: a multicentre randomized controlled trial. The New England Journal of Medicine. Oct 5, 2023. DOI:10.1056/NEJMoa2303911
-
The Annual General Meeting of Ypsomed Holding AG approved all proposals of the Board of Directors on 26 June 2024. Around 500 shareholders attended the event in Burgdorf. They confirmed all members of the Board of Directors in office and re-elected Gilbert Achermann as Chairman of the Board of Directors 👍. #Ypsomed #AnnualGeneralMeeting2024 #40YearsYpsomed
Annual General Meeting of Ypsomed approves all proposals
ypsomed.com